Cargando…

The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus

BACKGROUND: Patients with type 2 diabetes mellitus (T2DM) present subclinical left ventricular systolic and/or diastolic dysfunction (LVD). Dipeptidyl peptidase-4 (DPP4) inactivates peptides that possess cardioprotective actions. Our aim was to analyze whether the activity of circulating DPP4 is ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravassa, Susana, Barba, Joaquín, Coma-Canella, Isabel, Huerta, Ana, López, Begoña, González, Arantxa, Díez, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852480/
https://www.ncbi.nlm.nih.gov/pubmed/24099410
http://dx.doi.org/10.1186/1475-2840-12-143
_version_ 1782478670045118464
author Ravassa, Susana
Barba, Joaquín
Coma-Canella, Isabel
Huerta, Ana
López, Begoña
González, Arantxa
Díez, Javier
author_facet Ravassa, Susana
Barba, Joaquín
Coma-Canella, Isabel
Huerta, Ana
López, Begoña
González, Arantxa
Díez, Javier
author_sort Ravassa, Susana
collection PubMed
description BACKGROUND: Patients with type 2 diabetes mellitus (T2DM) present subclinical left ventricular systolic and/or diastolic dysfunction (LVD). Dipeptidyl peptidase-4 (DPP4) inactivates peptides that possess cardioprotective actions. Our aim was to analyze whether the activity of circulating DPP4 is associated with echocardiographically defined LVD in asymptomatic patients with T2DM. METHODS: In this cross-sectional study, we examined 83 T2DM patients with no coronary or valve heart disease and 59 age and gender-matched non-diabetic subjects. Plasma DPP4 activity (DPP4a) was measured by enzymatic assay and serum amino-terminal pro-brain natriuretic peptide (NT-proBNP) was measured by enzyme-linked immunosorbent assay. LV function was assessed by two-dimensional echocardiographic imaging, targeted M-mode recordings and Doppler ultrasound measurements. Differences in means were assessed by t-tests and one-way ANOVA. Associations were assessed by adjusted multiple linear regression and logistic regression analyses. RESULTS: DPP4a was increased in T2DM patients as compared with non-diabetic subjects (5855 ± 1632 vs 5208 ± 957 pmol/min/mL, p < 0.05). Clinical characteristics and echocardiographic parameters assessing LV morphology were similar across DPP4a tertiles in T2DM patients. However, prevalence of LVD progressively increased across incremental DPP4a tertiles (13%, 39% and 71%, all p < 0.001). Multivariate regression analysis confirmed the independent associations of DPP4a with LVD in T2DM patients (p < 0.05). Similarly, multiple logistic regression analysis showed that an increase of 100 pmol/min/min plasma DPP4a was independently associated with an increased frequency of LVD with an adjusted odds ratio of 1.10 (95% CI, 1.04 to 1.15, p = 0.001). CONCLUSIONS: An excessive activity of circulating DPP4 is independently associated with subclinical LVD in T2DM patients. Albeit descriptive, these findings suggest that DPP4 may be involved in the mechanisms of LVD in T2DM.
format Online
Article
Text
id pubmed-3852480
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38524802013-12-06 The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus Ravassa, Susana Barba, Joaquín Coma-Canella, Isabel Huerta, Ana López, Begoña González, Arantxa Díez, Javier Cardiovasc Diabetol Original Investigation BACKGROUND: Patients with type 2 diabetes mellitus (T2DM) present subclinical left ventricular systolic and/or diastolic dysfunction (LVD). Dipeptidyl peptidase-4 (DPP4) inactivates peptides that possess cardioprotective actions. Our aim was to analyze whether the activity of circulating DPP4 is associated with echocardiographically defined LVD in asymptomatic patients with T2DM. METHODS: In this cross-sectional study, we examined 83 T2DM patients with no coronary or valve heart disease and 59 age and gender-matched non-diabetic subjects. Plasma DPP4 activity (DPP4a) was measured by enzymatic assay and serum amino-terminal pro-brain natriuretic peptide (NT-proBNP) was measured by enzyme-linked immunosorbent assay. LV function was assessed by two-dimensional echocardiographic imaging, targeted M-mode recordings and Doppler ultrasound measurements. Differences in means were assessed by t-tests and one-way ANOVA. Associations were assessed by adjusted multiple linear regression and logistic regression analyses. RESULTS: DPP4a was increased in T2DM patients as compared with non-diabetic subjects (5855 ± 1632 vs 5208 ± 957 pmol/min/mL, p < 0.05). Clinical characteristics and echocardiographic parameters assessing LV morphology were similar across DPP4a tertiles in T2DM patients. However, prevalence of LVD progressively increased across incremental DPP4a tertiles (13%, 39% and 71%, all p < 0.001). Multivariate regression analysis confirmed the independent associations of DPP4a with LVD in T2DM patients (p < 0.05). Similarly, multiple logistic regression analysis showed that an increase of 100 pmol/min/min plasma DPP4a was independently associated with an increased frequency of LVD with an adjusted odds ratio of 1.10 (95% CI, 1.04 to 1.15, p = 0.001). CONCLUSIONS: An excessive activity of circulating DPP4 is independently associated with subclinical LVD in T2DM patients. Albeit descriptive, these findings suggest that DPP4 may be involved in the mechanisms of LVD in T2DM. BioMed Central 2013-10-07 /pmc/articles/PMC3852480/ /pubmed/24099410 http://dx.doi.org/10.1186/1475-2840-12-143 Text en Copyright © 2013 Ravassa et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Investigation
Ravassa, Susana
Barba, Joaquín
Coma-Canella, Isabel
Huerta, Ana
López, Begoña
González, Arantxa
Díez, Javier
The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus
title The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus
title_full The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus
title_fullStr The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus
title_full_unstemmed The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus
title_short The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus
title_sort activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852480/
https://www.ncbi.nlm.nih.gov/pubmed/24099410
http://dx.doi.org/10.1186/1475-2840-12-143
work_keys_str_mv AT ravassasusana theactivityofcirculatingdipeptidylpeptidase4isassociatedwithsubclinicalleftventriculardysfunctioninpatientswithtype2diabetesmellitus
AT barbajoaquin theactivityofcirculatingdipeptidylpeptidase4isassociatedwithsubclinicalleftventriculardysfunctioninpatientswithtype2diabetesmellitus
AT comacanellaisabel theactivityofcirculatingdipeptidylpeptidase4isassociatedwithsubclinicalleftventriculardysfunctioninpatientswithtype2diabetesmellitus
AT huertaana theactivityofcirculatingdipeptidylpeptidase4isassociatedwithsubclinicalleftventriculardysfunctioninpatientswithtype2diabetesmellitus
AT lopezbegona theactivityofcirculatingdipeptidylpeptidase4isassociatedwithsubclinicalleftventriculardysfunctioninpatientswithtype2diabetesmellitus
AT gonzalezarantxa theactivityofcirculatingdipeptidylpeptidase4isassociatedwithsubclinicalleftventriculardysfunctioninpatientswithtype2diabetesmellitus
AT diezjavier theactivityofcirculatingdipeptidylpeptidase4isassociatedwithsubclinicalleftventriculardysfunctioninpatientswithtype2diabetesmellitus
AT ravassasusana activityofcirculatingdipeptidylpeptidase4isassociatedwithsubclinicalleftventriculardysfunctioninpatientswithtype2diabetesmellitus
AT barbajoaquin activityofcirculatingdipeptidylpeptidase4isassociatedwithsubclinicalleftventriculardysfunctioninpatientswithtype2diabetesmellitus
AT comacanellaisabel activityofcirculatingdipeptidylpeptidase4isassociatedwithsubclinicalleftventriculardysfunctioninpatientswithtype2diabetesmellitus
AT huertaana activityofcirculatingdipeptidylpeptidase4isassociatedwithsubclinicalleftventriculardysfunctioninpatientswithtype2diabetesmellitus
AT lopezbegona activityofcirculatingdipeptidylpeptidase4isassociatedwithsubclinicalleftventriculardysfunctioninpatientswithtype2diabetesmellitus
AT gonzalezarantxa activityofcirculatingdipeptidylpeptidase4isassociatedwithsubclinicalleftventriculardysfunctioninpatientswithtype2diabetesmellitus
AT diezjavier activityofcirculatingdipeptidylpeptidase4isassociatedwithsubclinicalleftventriculardysfunctioninpatientswithtype2diabetesmellitus